Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial

Zheng, 2001, Sudden cardiac death in the United States, 1989–1998, Circulation, 104, 2158, 10.1161/hc4301.098254 Huikuri, 2001, Sudden death due to cardiac arrhythmias, N Engl J Med, 345, 1473, 10.1056/NEJMra000650 Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 Bigger, 2002, Expanding indications for implantable cardiac defibrillators, N Engl J Med, 346, 931, 10.1056/NEJMe020011 Nolan, 1998, Prospective study of heart rate variability and mortality in chronic heart failure, Circulation, 98, 1510, 10.1161/01.CIR.98.15.1510 Fauchier, 1999, Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy, J Am Coll Cardiol, 33, 1203, 10.1016/S0735-1097(99)00021-2 Kadish, 2000, Defibrillators in nonischemic cardiomyopathy treatment evaluation, Pacing Clin Electrophysiol, 23, 338, 10.1111/j.1540-8159.2000.tb06759.x Doval, 1996, Nonsustained ventricular tachycardia in severe heart failure, Circulation, 94, 3198, 10.1161/01.CIR.94.12.3198 1996, Heart rate variability, Circulation, 93, 1043, 10.1161/01.CIR.93.5.1043 Epstein, 1996, Classification of death in antiarrhythmia trials, J Am Coll Cardiol, 27, 433, 10.1016/0735-1097(95)00482-3 Guzzetti, 2005, Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure, Eur Heart J, 26, 357, 10.1093/eurheartj/ehi067 Boveda, 2001, Prognostic value of heart rate variability in time domain analysis in congestive heart failure, J Interv Card Electrophysiol, 5, 181, 10.1023/A:1011485609838 Hohnloser, 2003, Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy, J Am Coll Cardiol, 41, 2220, 10.1016/S0735-1097(03)00467-4 Grimm, 2003, Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy. Results of the Marburg Cardiomyopathy Study, Circulation, 108, 2883, 10.1161/01.CIR.0000100721.52503.85 Rashba, 2004, Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation, J Cardiovasc Electrophysiol, 15, 170, 10.1046/j.1540-8167.2004.03428.x Dries, 1998, Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction, J Am Coll Cardiol, 32, 695, 10.1016/S0735-1097(98)00297-6 Middlekauff, 1991, Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients, Circulation, 84, 40, 10.1161/01.CIR.84.1.40